Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Personalized medicine: a windfall for science, but what about patients?

Browman G, Hébert PC, Coutts J, Stanbrook MB, Flegel K, MacDonald NE.

CMAJ. 2011 Dec 13;183(18):E1277. doi: 10.1503/cmaj.110607. Epub 2011 Jul 18. No abstract available.

2.

A new era of genetic testing and its impact on research and clinical care.

Baudhuin LM.

Clin Chem. 2012 Jun;58(6):1070-1. No abstract available.

3.

Strong medicine for French research. Arnold Munnich interviewed by Declan Butler.

Munnich A.

Nature. 2010 Jul 1;466(7302):20. doi: 10.1038/466020a. No abstract available.

PMID:
20595986
4.

Clinical epidemiologists and EBM proponents need to be able to critically appraise 'Omics,' the fatal flaw of Personalized Medicine.

Tugwell P, Knottnerus JA, Idzerda L.

J Clin Epidemiol. 2010 Sep;63(9):943-4. doi: 10.1016/j.jclinepi.2010.06.006. No abstract available.

PMID:
20656192
5.

What to expect from the Pharmacogenomics Research Network.

Long RM, Berg JM.

Clin Pharmacol Ther. 2011 Mar;89(3):339-41. doi: 10.1038/clpt.2010.293. No abstract available.

PMID:
21326260
6.

Informatics research to enable clinically relevant, personalized genomic medicine.

Ohno-Machado L.

J Am Med Inform Assoc. 2012 Mar-Apr;19(2):149-50. doi: 10.1136/amiajnl-2012-000844. No abstract available.

7.

Personalized medicine: potential impact on the biopharmaceutical industry.

Malik NN, Khan Y.

Drug Discov Today. 2010 Nov;15(21-22):881-3. doi: 10.1016/j.drudis.2010.08.019. Epub 2010 Sep 15. No abstract available.

PMID:
20833263
8.
9.

[Personalized medicine. So close and so far away].

Meléndez-Zajgla J.

Rev Invest Clin. 2009 Nov-Dec;61(6):454-5. Spanish. No abstract available.

PMID:
20184124
10.

Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?

Roukos DH.

Expert Rev Mol Diagn. 2010 Apr;10(3):247-50. doi: 10.1586/erm.10.10. No abstract available.

PMID:
20370580
11.

[Clinical trials and personalized medicine in oncology?].

Arnold D, Bokemeyer C.

Onkologie. 2010;33 Suppl 7:25-9. doi: 10.1159/000319739. Epub 2010 Sep 16. German.

PMID:
20926911
12.

Are there any differences in the regulations of personalized medicine among the USA, EU and Japan?

Shimazawa R, Ikeda M.

Br J Clin Pharmacol. 2013 May;75(5):1365-7. doi: 10.1111/j.1365-2125.2012.04462.x. No abstract available.

13.

P4 medicine: the future around the corner.

Sobradillo P, Pozo F, Agustí A.

Arch Bronconeumol. 2011 Jan;47(1):35-40. doi: 10.1016/j.arbres.2010.09.009. Epub 2010 Dec 28. Review. English, Spanish.

14.

Research in the wild.

Van Hoyweghen I, Penders B.

Nature. 2007 Nov 22;450(7169):478. No abstract available.

PMID:
18033273
15.

Science and medicine: an endangered relationship.

Unschuld P.

Explore (NY). 2006 May;2(3):189-93. No abstract available.

PMID:
16781637
16.

Biomarkers research in Europe: focus on personalized medicine.

Metodiev MV.

Expert Rev Mol Diagn. 2011 Sep;11(7):689-90. doi: 10.1586/erm.11.55.

PMID:
21902529
17.

Comparative effectiveness and personalized medicine: evolving together or apart?

Epstein R, Teagarden JR.

Health Aff (Millwood). 2010 Oct;29(10):1783-7. doi: 10.1377/hlthaff.2010.0642.

18.

Genetics/Genomics in chronic kidney disease--towards personalized medicine?

Luttropp K, Lindholm B, Carrero JJ, Glorieux G, Schepers E, Vanholder R, Schalling M, Stenvinkel P, Nordfors L.

Semin Dial. 2009 Jul-Aug;22(4):417-22. doi: 10.1111/j.1525-139X.2009.00592.x. Review.

PMID:
19708993
19.

Data collection as a barrier to personalized medicine.

Zakim D, Schwab M.

Trends Pharmacol Sci. 2015 Feb;36(2):68-71. doi: 10.1016/j.tips.2014.11.002. Epub 2014 Dec 2. Review. Erratum in: Trends Pharmacol Sci. 2015 Apr;36(4):253.

PMID:
25479798
20.

Comparative effectiveness research and personalized medicine: catalyzing or colliding?

Epstein RS, Teagarden JR.

Pharmacoeconomics. 2010;28(10):905-13. doi: 10.2165/11535830-000000000-00000.

PMID:
20831298

Supplemental Content

Support Center